Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | NR2F1 |
| Upstream (Parents) |
|---|
| (<<) PEG3 → NR2F1 |
| (<<) ANKRD30A → NR2F1 |
| (<<) MEOX2 → NR2F1 |
| (<<) HOPX → NR2F1 |
| (<<) ETV1 → NR2F1 |
| (<<) RUNX1T1 → NR2F1 |
| (<<) EBF1 → NR2F1 |
| (<<) ERG → NR2F1 |
| (<<) ZFHX4 → NR2F1 |
| (<<) HIC1 → NR2F1 |
| (<<) HOXD8 → NR2F1 |
| (<<) NFATC4 → NR2F1 |
| Downstream (Children) |
|---|
| NR2F1 → GATA6 (>>) |
| NR2F1 → ARX (>>) |
| NR2F1 → PGR (>>) |
| NR2F1 → MECOM (>>) |
| NR2F1 → TSHZ2 (>>) |
| NR2F1 → MEIS2 (>>) |
| NR2F1 → MEOX1 (>>) |
| NR2F1 → NR3C2 (>>) |
| NR2F1 → SMAD9 (>>) |
| NR2F1 → CSRNP3 (>>) |
| NR2F1 → MEIS1 (>>) |
| NR2F1 → ALX1 (>>) |
| NR2F1 → TWIST2 (>>) |
| NR2F1 → TSHZ1 (>>) |
| NR2F1 → CBFA2T3 (>>) |
| NR2F1 → TCEAL1 (>>) |
| NR2F1 → GATAD2A (>>) |
| NR2F1 → GLI2 (>>) |
